FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in South Korea

Biotech startups in South Korea

Updated 16 Nov 2026

Reset
Biotech startups in South Korea
One-time CSV
  • 340 funded companies, 215 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~south-korea.csv340 rows × 18 columns
CompanyCityLast roundAmountDate
HITSSeoulSeries B$13.5M2026-09-28
GaluxDogokdongSeries B$29.0M2026-02-09
ApollonSeoulSeries A$3.7M2026-09-22
StandigmSeoulSeries D$10.0M2021-06-30
CelloidSeongnamSeries A$6.1M2026-03-12
PharmCADDBusanSeries B$16.0M2021-04-19
DeargenDaejeonSeries B$16.6M2022-02-24
LN RoboticsHanamSeries B$14.5M2024-07-09

8 rows of the CSV in 5 of its 18 columns.

340
Startups
$1.6B
Total raised
23
Funded in the last 12 months
$188.9M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

16 of 340
16 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
HITS HITS develops artificial intelligence software for drug discovery and pharmaceutical research. Artificial intelligence Seoul Series B $13.5M 2026-09-28 $25.1M Korea Investment Partners, Capstone Partners, Company K Partners +2 11 to 50 2020
Apollon Apollon develops noninvasive continuous glucose monitoring systems. Artificial intelligence Seoul Series A $3.7M 2026-09-22 $6.4M TIPS Program, KB Investment, TheVentures +2 11 to 50 2021
Celloid Celloid supplies a 3D cell culture medium that supports quality-controlled long-term cultivation of organoids. Biotech Seongnam Series A $6.1M 2026-03-12 $7.9M FuturePlay, POSTECH Holdings 1 to 10 2021
Galux Galux designs molecules to discover new drugs for incurable and rare diseases. Artificial intelligence Dogokdong Series B $29.0M 2026-02-09 $36.3M Dayli Partners 11 to 50 2020
Cure Stream Cure Stream develops an autonomous artificial pancreas system that uses an AI algorithm to decide hormone injections. Artificial intelligence Daegu Series A $7.8M 2025-05-14 $7.8M TIPS Program 2019
LN Robotics LN Robotics is a technology research firm that develops medical robots. Biotech Hanam Series B $14.5M 2024-07-09 $21.3M TIPS Program, Bluepoint, Mirae Asset Venture Investment +2 11 to 50 2019
Space Lintech Space Lintech manufactures medications for use in satellites and space stations. Biotech Daejeon Series A $2.9M 2024-04-11 $2.9M Company K Partners, Woori Venture Partners 1 to 10 2021
Surginex Surginex develops biological drugs and offers molecular biology, genetics, and physical and chemical analysis services. Biotech Seocho Series B $6.3M 2024-03-28 Hana Ventures, Laguna Investment, Partners Investment +1 1 to 10 2020
Ultimate Potential Ultimate Potential is a brand offering hyper-personalized sports nutrition. Biotech Seoul Seed $39K 2023-12-26 CNTTECH, Strong Ventures 11 to 50 2020
Novorex Novorex develops molecule drugs for oncology and neurology diseases. Biotech Seongnam Series A $8.9M 2023-11-21 $8.9M TIPS Program, KB Investment, Hana Ventures +2 1 to 10 2020
Plcoskin Plcoskin is a MedTech company that offers reconstructive plastic surgery and regenerative skincare. Biotech Seoul Series B $4.5M 2023-08-31 TIPS Program, Primer, We Ventures +1 11 to 50 2018
Deargen Deargen provides AI-based genome analysis services. Artificial intelligence Daejeon Series B $16.6M 2022-02-24 TIPS Program, Hana Ventures, The Wells Investment 51 to 100 2016
NetTargets NetTargets provides AI-focused drug discovery research services. Artificial intelligence Yusong Series A $5.3M 2021-07-02 TIPS Program, Bluepoint, WE Ventures +2 11 to 50 2019
PharmCADD PharmCADD uses AI protein structure prediction, molecular dynamics, and quantum calculations to speed drug design. Artificial intelligence Busan Series B $16.0M 2021-04-19 DSC Investment, KB Securities, KDB Capital +1 51 to 100 2019
Biobab AiBIO Biobab AiBIO is a biotechnology company developing drugs using artificial intelligence. Artificial intelligence Incheon Series A $14.1M 2021-03-15 $14.1M Mirae Asset Venture Investment, Aju IB Investment, Mirae Asset Capital +2 11 to 50 2018
Looxid Labs Looxid Labs integrates emotion recognition with virtual reality using eye and brain interface technology. Artificial intelligence Seoul Series A $4.0M 2018-11-12 TIPS Program, Samsung Ventures, Bluepoint +2 1 to 10 2015

Table 1. Biotech startups in South Korea: the 16 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 340.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Galux Galux designs molecules to discover new drugs for incurable and rare diseases. Artificial intelligence Dogokdong Series B $29.0M 2026-02-09 $36.3M Dayli Partners 11 to 50 2020
2 HITS HITS develops artificial intelligence software for drug discovery and pharmaceutical research. Artificial intelligence Seoul Series B $13.5M 2026-09-28 $25.1M Korea Investment Partners, Capstone Partners, Company K Partners +2 11 to 50 2020
3 Celloid Celloid supplies a 3D cell culture medium that supports quality-controlled long-term cultivation of organoids. Biotech Seongnam Series A $6.1M 2026-03-12 $7.9M FuturePlay, POSTECH Holdings 1 to 10 2021
4 Apollon Apollon develops noninvasive continuous glucose monitoring systems. Artificial intelligence Seoul Series A $3.7M 2026-09-22 $6.4M TIPS Program, KB Investment, TheVentures +2 11 to 50 2021

Table 2. Biotech startups in South Korea: the 4 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 TIPS Program Startup incubator Gangneung, South Korea 14 4% 1 Apollon
2 Company K Partners Venture capital firm Ilsangu, South Korea 4 1% 1 HITS
3 KB Investment Private equity firm Seoul, South Korea 4 1% 1 Apollon
4 Mirae Asset Venture Investment Venture capital firm Seongnam, South Korea 4 1%
5 Bluepoint Startup accelerator Daejeon, South Korea 4 1%
6 STIC Ventures Venture capital firm Seoul, South Korea 3 1% 2 HITS, Apollon
7 Hana Ventures Corporate venture arm Seoul, South Korea 3 1%
8 Mirae Asset Capital Investment bank Seoul, South Korea 3 1%
9 UTC Investment Co. Venture capital firm Seoul, South Korea 3 1%
10 Kiwoom Investment Venture capital firm Youidodong, South Korea 2 1% 1 HITS
11 Korea Investment Partners Private equity firm Seoul, South Korea 2 1% 1 HITS
12 TheVentures Venture capital firm Seoul, South Korea 2 1% 1 Apollon
13 Future Science and Technology Holdings Venture capital firm Daejeon, South Korea 2 1% 1 Apollon
14 Kolon Investment Private equity firm Seoul, South Korea 2 1%
15 Woori Venture Partners Private equity firm Seongnam, South Korea 2 1%

Table 3. Biotech startups in South Korea: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 282 83% $1.4B
Software 32 9% $132.6M
Artificial intelligence 23 7% $97.5M
Hardware 19 6% $54.2M
Cybersecurity 3 1%
Education 1 0%
Commerce 1 0%
Fintech 1 0%
Energy 1 0%

Table 4. Biotech startups in South Korea by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 21 6% $223K
Seed 123 36% $842K
Series A 84 25% $4.2M
Series B 75 22% $10.4M
Series C 34 10% $14.9M
Series D+ 3 1% $10.0M

Table 5. Biotech startups in South Korea by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Seoul 121 36%
Seongnam 41 12%
Daejeon 21 6%
Incheon 14 4%
Suwon 12 4%
Pohang 8 2%
Seocho 8 2%
Cheongju 8 2%
Yusong 6 2%
Seongdong 5 1%
Daegu 5 1%
Chuncheon 5 1%

Table 6. Biotech startups in South Korea by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 4%
October 2026 2 9% $24.9M
September 2026 5 22% $39.3M
August 2026 2 9% $8.8M
July 2026 1 4% $6.7M
June 2026 2 9% $14.0M
April 2026 1 4%
March 2026 4 17% $53.4M
February 2026 2 9% $30.5M
December 2025 3 13% $11.3M

Table 7. Biotech startups in South Korea: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 20 6% $177.6M
2025 23 7% $150.2M
2024 35 10% $191.6M
2023 53 16% $183.7M
2022 71 21% $465.1M
2021 71 21% $923.3M

Table 8. Biotech startups in South Korea by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 16 5%
2020 to 2022 102 31%
2015 to 2019 173 52%
2010 to 2014 24 7%
Before 2010 15 5%

Table 9. Biotech startups in South Korea by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 84 33%
11 to 50 142 56%
51 to 100 24 9%
101 to 250 3 1%
501 to 1,000 2 1%

Table 10. Biotech startups in South Korea by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in South Korea are on the list?
340, in the file dated 16 November 2026. 23 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 340 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in South Korea: 340 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech startups in South Korea by funding stage

Other sectors in South Korea

Biotech startups elsewhere

Cite: FundingWatcher, 340 funded biotech companies in South Korea, 16 November 2026. https://fundingwatcher.com/startups/biotech/south-korea/